But CD8 T cells are believed to be the main contributor to the anti‐tumor efficacy of cell therapy, and CD8 CAR‐T cell adoptive transfer alone has been shown to be sufficient for long‐term B cell eradication.46 This evidence concerns the gene CD8A and neoplasm.